CAS: 2130996-00-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GLPG2938 REF: IN-DA01X7A2CAS: 2130996-00-6 | 97% | 195.00 €~525.00 € | Tue 07 Jan 25 |
 | GLPG2938 REF: TM-T9199CAS: 2130996-00-6 | 98.25% | 83.00 €~1,079.00 € | Mon 13 Jan 25 |
 | GLPG2938 REF: 3D-FKD99600CAS: 2130996-00-6 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: IN-DA01X7A2
| 25mg | 195.00 € | ||
| 50mg | 328.00 € | ||
| 100mg | 525.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
GLPG2938
CAS:2130996-00-6
GLPG2938 (1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea) is a potent and
Formula:
C20H19F6N7O2
Purity:
98.25%
Color and Shape:
Solid
Molecular weight:
503.4
Ref: TM-T9199
| 1mg | 83.00 € | ||
| 5mg | 159.00 € | ||
| 10mg | 271.00 € | ||
| 25mg | 542.00 € | ||
| 50mg | 782.00 € | ||
| 100mg | 1,079.00 € | ||
| 1mL*10mM (DMSO) | 168.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
GLPG2938
CAS:2130996-00-6
GLPG2938 is a small molecule inhibitor of the extracellular, membrane-bound form of the human insulin …
Formula:
C20H19F6N7O2
Purity:
Min. 95%
Molecular weight:
503.40 g/mol
Ref: 3D-FKD99600
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
